公司概覽
業務類別 Diagnostics & Research
業務概覽 Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company's main franchises are Guardant360 for genomic profiling of tumors, Reveal for molecular residual disease testing, and Shield for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
公司地址 3100 Hanover Street, Palo Alto, CA, USA, 94304
電話號碼 +1 855 698-8887
傳真號碼 +1 888 974-4258
公司網頁 https://www.guardanthealth.com
員工數量 2506
 
公司高管 / 董事會成員
公司高管
高管 職務 年薪 更新日期
Ms. Darya Chudova Chief Technology Officer 美元 487.31K 29/04/2025
Ms. Terilyn Juarez Monroe Chief People Officer 美元 439.62K 29/04/2025
Mr. John G. Saia Chief Legal Officer and Corporate Secretary 美元 509.23K 29/04/2025
Mr. Michael Brian Bell Chief Financial Officer and Principal Accounting Officer 美元 535.00K 19/02/2026
Dr. Helmy Eltoukhy, PhD Co-Chief Executive Officer and Chairman of the Board -- 19/02/2026
Mr. Kumud Kalia Chief Information Officer -- 29/04/2025
Dr. AmirAli Talasaz, PhD Co-Chief Executive Officer and Director -- 19/02/2026
Mr. Christopher Freeman Chief Commercial Officer -- 29/04/2025
Dr. Craig Eagle, M.D. Chief Medical Officer -- 29/04/2025
 
董事會成員
董事會 職務 更新日期
Mr. Ian T. Clark Lead Independent Director 19/02/2026
Mr. Musa Tariq Independent Director 19/02/2026
Ms. Myrtle S. Potter Independent Director 19/02/2026
Ms. Vijaya Gadde Independent Director 19/02/2026
Dr. Manuel Hidalgo Medina, M.D.,PhD Independent Director 19/02/2026
Mr. Alex M. Azar,II Director 19/02/2026
Mr. Roberto A. Mignone Independent Director 19/02/2026
Dr. Helmy Eltoukhy, PhD Co-Chief Executive Officer and Chairman of the Board 19/02/2026
Dr. AmirAli Talasaz, PhD Co-Chief Executive Officer and Director 19/02/2026
Ms. Meghan V. Joyce Independent Director 19/02/2026
Mr. Steven E. Krognes, M.B.A. Independent Director 19/02/2026
 
所屬ETF (更新日期: 07/03/2026 02:15)
代號 名稱 佔比% 持有日期
HQHabrdn Healthcare Investors0.04%31/01/2026
PRFZInvesco RAFI US 1500 Small-Mid ETF0.04%27/02/2026
BBMCJPMorgan BetaBuilders US Mid Cap Eq ETF0.04%27/02/2026
PTHInvesco Dorsey Wright Healthcare MomtETF0.04%27/02/2026
ESMLiShares ESG Aware MSCI USA Small-Cap ETF0.04%28/02/2026
FNXFirst Trust Mid Cap Core AlphaDEX® ETF0.03%26/02/2026
DFACDimensional US Core Equity 2 ETF0.03%27/02/2026
FBCGFidelity Blue Chip Growth ETF0.03%31/01/2026
HQLabrdn Life Sciences Investors0.03%31/01/2026
ISCGiShares Morningstar Small-Cap Growth ETF0.03%28/02/2026
VFMOVanguard US Momentum Factor ETF0.03%31/12/2025
DFUSDimensional US Equity Market ETF0.03%27/02/2026
FNYFirst Trust Mid Cap Growth AlphaDEX® ETF0.03%26/02/2026
FRTYAlger Mid Cap 40 ETF0.03%27/02/2026
IWViShares Russell 3000 ETF0.03%28/02/2026
JHMMJHancock Multifactor Mid Cap ETF0.02%27/02/2026
NUSCNuveen ESG Small-Cap ETF0.02%27/02/2026
ONEQFidelity Nasdaq Composite ETF0.02%27/02/2026
JHSCJHancock Multifactor Small Cap ETF0.02%27/02/2026
USVMVictoryShares US Sm Md Cp Val Momt ETF0.02%27/02/2026
  1   2    3    4    5    6    7  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.